Novartis Stock Falls 12% on Its Third Trial Setback In a Week
pharma_trial_failureGlobalYahoo Finance8 Sept, 13:10 UTC
Context
Novartis Stock Falls 12% on Its Third Trial Setback In a Week Yahoo Finance Pharma major Novartis falls 10% after three drug trial setbacks CNBC Novartis twin drug setbacks pile pressure on pipeline and CEO Yahoo Finance Novartis stock slides as centerpiece of $12B Avidity buyout flunks ‘crucial’ phase 3 test Fierce Biotech Novartis Stock Drops After Another Trial Setback WSJ
What it means
Causal chain
No clear market signal
How to read a signal
- Severity
- the event's market impact, 1–5
- Direction
- ↑ / ↓ likely price move for the asset
- Exp. move
- the size of the abnormal move we'd expect if the call plays out — not a claim a move will happen:Most flagged events don't move beyond noise; those count against us (see the track record).Ssmall<1%Mmoderate1–5%Llarge>5%
- Timeframe
- the window we measure over:1dshort5dmedium21dlong
- Conviction
- how well-established the directional call is (textbook → speculative) — not a guaranteed outcome:lowaveragestrong
Get the next signal the moment it breaks.
The full live feed, asset filters, and alerts — free.
Sign up free →Not investment advice · for informational purposes only. Generated 8 Sept, 18:18 UTC